Bio Rad Laboratories Inc (NYSE:BIO)

343.27
Delayed Data
As of Oct 18
 -0.18 / -0.05%
Today’s Change
220.05
Today|||52-Week Range
348.39
+47.82%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$8.5B

Company Description

Bio-Rad Laboratories, Inc. engages in the development and production of specialty chemicals used in biochemical, pharmaceutical, and other life science research applications. It operates through the following segments: Life Sciences and Clinical Diagnostics. The Life Science segment develops, manufactures and markets reagents, apparatus, and laboratory instruments. The Clinical Diagnostics segment designs, manufactures, sells and supports test systems, informatics systems, test kits and specialize in quality controls that serve clinical laboratories in the global diagnostics market. The company was founded by David S. Schwartz and Alice N. Schwartz in 1952 and is headquartered in Hercules, CA.

Contact Information

Bio-Rad Laboratories, Inc.
1000 Alfred Nobel Drive
Hercules California 94547
P:(510) 724-7000
Investor Relations:

Employees

Shareholders

Mutual fund holders43.32%
Other institutional32.91%
Individual stakeholders26.34%

Top Executives

There are no executives to display.